Stocks listed in Europe look poised to open broadly higher on Friday, as investors assess the latest trade policy announcements out of the White House.
Futures tied to London’s FTSE 100 were last seen trading 0.2% higher, while those tied to the German DAX index were up 0.2% and France’s CAC 40 futures added 0.3%.
Overnight, President Donald Trump announced that pharmaceutical imports to the U.S. would be hit with 100% tariffs from Oct. 1. Companies who built manufacturing facilities in America would be exempt, Trump said, but only once they started breaking ground on the construction of U.S. plants.
Previously, Trump had threatened to impose tariffs of up to 200% on pharma imports.
Trump also announced on his Truth Social platform on Thursday night that heavy trucks would be slapped with 25% tariffs from next month.
In a note circulated in the wake of the announcements, JP Morgan strategists downplayed the impact the new tariffs would have on the pharmaceutical sector.
“[The] potential 100% tariff should largely be avoidable with us based manufacturing buildout,” they said. “And while there remain a number of unknowns on tonight’s announcement … we continue to see a very manageable overall impact from tariffs to our large cap coverage.”
The European Union’s own trade policies are also in focus, after German newspaper Handelsblatt reported that the bloc was planning to impose tariffs of up to 50% on Chinese steel in the coming weeks.
On Thursday, European stocks closed lower following the Trump administration’s launch of a national security probe into medical device imports, which could pave the way for further tariffs.
Overnight in Asia, pharma stocks notched losses as investors reacted to the looming U.S. tariffs on the sector.
In terms of economic data, Friday will see the release of Spain’s latest inflation print, U.K. mortgage lending figures, and a report on European economic sentiment.
